Cargando…
Analysis of RANK-c interaction partners identifies TRAF3 as a critical regulator of breast cancer aggressiveness
Breast cancer is a highly heterogeneous disease both at the histological and molecular levels. We have previously shown that RANK-c is a regulator of NF-κB signaling and exerts a suppressive effect on aggressive properties of ER negative breast cancer cells, while there is an opposite effect on ER p...
Autores principales: | Sirinian, Chaido, Papanastasiou, Anastasios D., Karayel, Ozge, Degn, Soren E., Peroukidis, Stavros, Chaniotis, Dimitrios, Nonni, Afrodite, Repanti, Maria, Kriegsmann, Mark, Makatsoris, Thomas, Koutras, Angelos, Mann, Matthias, Kalofonos, Haralabos P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475314/ https://www.ncbi.nlm.nih.gov/pubmed/36095928 http://dx.doi.org/10.1016/j.neo.2022.100836 |
Ejemplares similares
-
RANK-C Expression Sensitizes ER-Negative, EGFR-Positive Breast Cancer Cells to EGFR-Tyrosine Kinase Inhibitors (TKIs)
por: Sirinian, Chaido, et al.
Publicado: (2021) -
Cellular Senescence in Normal Mammary Gland and Breast Cancer. Implications for Cancer Therapy
por: Sirinian, Chaido, et al.
Publicado: (2022) -
Correction to: Identification of novel human RANK isoforms generated through alternative splicing. Implications in breast cancer cell survival and migration
por: Papanastasiou, Anastasios D., et al.
Publicado: (2018) -
Identification of novel human receptor activator of nuclear factor-kB isoforms generated through alternative splicing: implications in breast cancer cell survival and migration
por: Papanastasiou, Anastasios D, et al.
Publicado: (2012) -
Ulcerative colitis six years after colon cancer: only a coincidence?
por: Sakellakis, Minas, et al.
Publicado: (2014)